HomeBusiness NewsRiassunto: Presentati al congresso EHA2025 i dati positivi aggiornati per la terapia...

Riassunto: Presentati al congresso EHA2025 i dati positivi aggiornati per la terapia mutCALR mirata …

June 16, 2025

- Advertisement -

WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) ha annunciato oggi i primi dati clinici di due studi per la valutazione della sicurezza, della tollerabilità e dell’efficacia di INCA033989, un nuovo anticorpo monoclonale mirato, primo nella sua categoria, scoperto da Incyte, in pazienti…

Click here to view the original article.

Tags
Business Wire

- Advertisment -

Wall Street slumps on Middle East attacks, ASX set to slide; Oil prices surge

Pentland criticises early election, opposes AFL stadium | The Examiner

Riassunto: Presentati al congresso EHA2025 i dati positivi aggiornati per la terapia mutCALR mirata …

Recently Viewed

Balcatta woman in stable condition after baby’s death

$71 million, 124 apartment block approved for development opposite Northern Beaches Hospital and more in this week’s DA round up

Country Road breaks silence over store closures and plummeting sales

Marc Marquez supreme again at German Grand Prix

FEATURED

Great White shark bites fishing boat off Sunshine Coast

Volcanic cloud from Whakaari White Island halts flights

Great Koala Count: Aussies urged to track sightings of iconic marsupials

POPULAR POSTS

'State first': Tassie miners spending millions to go 'cleaner and greener'

Halter Dresses Are Summer’s Biggest Comeback Trend

Princeton study maps 200,000 years of Human–Neanderthal interbreeding

POPULAR CATEGORY

FOLLOW US

Riassunto: Presentati al congresso EHA2025 i dati positivi aggiornati per la terapia mutCALR mirata …

RELATED ARTICLES

Recently Viewed

FEATURED

POPULAR POSTS

POPULAR CATEGORY

FOLLOW US